Skip to Main Content
Welcome to theĀ Scientist.comĀ Marketplace

Go to Main Navigation

BP2754b

TAL1 Antibody (S122) Blocking Peptide

Abcepta

DETAILS

  • Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
  • Gene Id: 6886
  • Category: Peptides; Blocking Peptides
  • Subtitle: Synthetic peptide
  • Gene Name: TAL1
  • Other Names: T-cell acute lymphocytic leukemia protein 1, TAL-1, Class A basic helix-loop-helix protein 17, bHLHa17, Stem cell protein, T-cell leukemia/lymphoma protein 5, TAL1, BHLHA17, SCL, TCL5
  • Availability: 2 weeks
  • Bio Background: TAL1 is implicated in the genesis of hemopoietic malignancies. It may play an important role in hemopoietic differentiation. It serves as a positive regulator of erythroid differentiation.
  • Bio References: Kassouf,M.T., Blood 112 (4), 1056-1067 (2008)Terme,J.M., J. Virol. 82 (16), 7913-7922 (2008)Brunet de la Grange,P., Stem Cells 26 (6), 1658-1662 (2008)
  • Primary Accession: P17542
  • Targetspecificity: The synthetic peptide sequence used to generate the antibody AP2754b was selected from the S122 region of human TAL1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.